Orris
attachment
attachment

This a old thyroid hormone report

Reading File
Finding Sources
analyse_media
Here is a clear breakdown and interpretation of Mr. Narain Karthi's thyroid function report:

Thyroid Function Report - Mr. Narain Karthi

Age: 20.11 years | Gender: Male | Collected: 08/01/2026 | Referred by: Dr. Muthukumaran

Results at a Glance

TestObserved ValueUnitReference RangeStatus
FT3 (Free Triiodothyronine)3.78pg/mL2.0 - 4.4✅ Normal
FT4 (Free Thyroxine)1.53ng/dL0.93 - 1.7✅ Normal
TSH (Thyroid Stimulating Hormone)1.39µIU/mL0.54 - 5.3✅ Normal

Interpretation

All three values are within normal limits. This is consistent with a euthyroid state - meaning the thyroid gland is functioning normally.
Here is what each test means:
  • FT3 (3.78 pg/mL) - Free T3 is the active thyroid hormone. His value sits comfortably in the middle of the normal range (2.0-4.4), indicating no excess or deficiency of the active hormone.
  • FT4 (1.53 ng/dL) - Free T4 is the precursor hormone produced by the thyroid gland, which gets converted to T3 in tissues. His value (1.53) is toward the upper-normal range but still fully within normal (0.93-1.7).
  • TSH (1.39 µIU/mL) - This pituitary hormone is the most sensitive indicator of thyroid function. A normal TSH (0.54-5.3) with normal FT3 and FT4 confirms normal thyroid function. His TSH of 1.39 is well within range.

What This Means

ConditionTSHFT4FT3
Normal (Euthyroid)NormalNormalNormal
HypothyroidismHighLowLow
HyperthyroidismLowHighHigh
Subclinical HypothyroidismHighNormalNormal
Subclinical HyperthyroidismLowNormalNormal
Mr. Karthi's results match the Normal pattern across all three parameters.

Key Points

  • No signs of hypothyroidism (underactive thyroid) or hyperthyroidism (overactive thyroid)
  • The report was collected in January 2026 - if there have been any new symptoms since then (fatigue, weight changes, hair loss, palpitations, heat/cold intolerance), a repeat test may be worthwhile
  • These are "free" hormone levels (FT3/FT4) which are more reliable than total T3/T4 as they are not affected by protein-binding changes from medications like oral contraceptives, androgens, or estrogens
  • The method used (ECLIA - Electrochemiluminescence Immunoassay) is a highly accurate and widely used laboratory technique
Bottom line: This is a completely normal thyroid panel. There is no evidence of thyroid dysfunction based on this report. For any symptoms or clinical concerns, please follow up with Dr. Muthukumaran.
⚠️ This analysis is for informational purposes only and does not replace professional medical advice. Always consult your doctor for clinical decisions.

Analyze the report

Based on the report already analyzed in our conversation, here is a thorough clinical analysis:

🔬 Thyroid Function Test - Clinical Analysis

Patient: Mr. Narain Karthi | Age: 20 years | Male Lab Date: January 8, 2026 | Referred by: Dr. Muthukumaran

📊 Parameter-by-Parameter Analysis

1. TSH - 1.39 µIU/mL (Ref: 0.54 - 5.3) ✅

TSH is the single most important thyroid screening test. It is secreted by the pituitary gland in response to thyroid hormone levels in the blood (negative feedback loop).
  • His value of 1.39 sits in the lower-middle of the normal range
  • This means the pituitary is not sensing any deficiency (which would drive TSH up) nor any excess (which would suppress TSH)
  • An ultrasensitive method was used, which can detect even very small deviations - making this result highly reliable
  • Conclusion: Pituitary-thyroid axis is functioning normally

2. FT4 - 1.53 ng/dL (Ref: 0.93 - 1.7) ✅

FT4 is the main hormone secreted by the thyroid gland itself.
  • His value of 1.53 is in the upper third of the normal range
  • This is completely normal and not a cause for concern
  • FT4 being toward the higher end with a mid-range TSH is a healthy pattern in young adults
  • Conclusion: Thyroid gland is producing adequate hormone

3. FT3 - 3.78 pg/mL (Ref: 2.0 - 4.4) ✅

FT3 is the biologically active form of thyroid hormone, largely produced by conversion of T4 in peripheral tissues (liver, kidneys, muscles).
  • His value of 3.78 is in the upper-middle of the normal range
  • Active hormone availability at tissue level is excellent
  • Conclusion: Peripheral conversion of T4 to T3 is functioning normally

🧠 Hormonal Axis Summary

Hypothalamus → TRH
      ↓
Pituitary → TSH (1.39 ✅) → Signals thyroid
      ↓
Thyroid Gland → FT4 (1.53 ✅) → Circulates in blood
      ↓
Peripheral Tissues → FT4 converts to FT3 (3.78 ✅)
      ↓
Cell-level thyroid action ✅
The entire hypothalamic-pituitary-thyroid (HPT) axis appears intact and well-regulated.

📌 What This Rules Out

ConditionRuled Out?Reason
Primary Hypothyroidism✅ YesTSH would be HIGH, FT4 LOW
Primary Hyperthyroidism✅ YesTSH would be LOW, FT4/FT3 HIGH
Subclinical Hypothyroidism✅ YesTSH would be mildly elevated
Subclinical Hyperthyroidism✅ YesTSH would be suppressed
Central Hypothyroidism✅ YesTSH LOW with low FT4
T3 toxicosis✅ YesTSH LOW, FT3 markedly HIGH
Sick Euthyroid Syndrome✅ YesFT3 typically LOW

⚠️ Important Clinical Caveats

  1. Report is from January 2026 (now August 2026 - 7 months old). Thyroid status can change, especially in young patients. If symptoms have emerged, a fresh panel is advisable.
  2. No Total T3/T4 done - Free hormone levels (FT3/FT4) are preferred and sufficient. No concern here.
  3. No Anti-TPO or Anti-Thyroglobulin antibodies tested - If there is a family history of thyroid disease or autoimmune conditions, antibody testing (especially Anti-TPO) would be a useful addition to screen for early Hashimoto's thyroiditis, which can be present even with normal hormone levels.
  4. Biotin interference - The lab itself cautions that high-dose Biotin supplements (>5 mg/day) can falsely affect ECLIA immunoassay results. If the patient was on Biotin, results may need reinterpretation.
  5. Time of collection - TSH has a circadian rhythm and is typically highest at night. Sample was collected at 9:15 AM, which is standard and acceptable.

✅ Overall Conclusion

Normal thyroid function (Euthyroid state). All three thyroid markers - TSH, FT4, and FT3 - are well within their reference ranges. There is no biochemical evidence of any thyroid disorder at the time of this test.
If this test was done as a routine screening or to evaluate non-specific symptoms (fatigue, weight changes, mood issues), the thyroid gland can be effectively excluded as the cause.
⚠️ This is an educational analysis only. Clinical correlation with symptoms is always necessary. Please consult Dr. Muthukumaran for medical advice.

This is his new report analyze it and give me the result and what might be the reason for the change and what he should do next

Reading File
Running Command

python3 -c " import pdfplumber with pdfplumber.open('/tmp/workspace/attachments/eea7838f-9452-497d-a23d-7864bb628ff3/Report.pdf') as pdf: for i, page in enumerate(pdf.pages): print(f'--- PAGE {i+1} ---') print(page.extract_text()) tables = page.extract_tables() if tables: for t_idx, table in enumerate(tables): print(f' [TABLE {t_idx+1}]') for row in table: print(' ', row) "

Finding Sources
Finding Sources
I now have everything needed for a comprehensive analysis. Here it is:

🔬 New Thyroid Report - Full Analysis

Patient: Mr. Narain Karthi | Age: 21.6 years | Male Collected: 12/08/2026 (Today) | Self-referred | Lab: Metropolis Healthcare (NABL Accredited)

📊 Side-by-Side Comparison: Old vs New

TestJan 2026 (Old)Aug 2026 (New)Reference RangeChange
FT33.78 pg/mL ✅2.74 pg/mL ✅2.0 - 4.4⬇️ Dropped (still normal)
FT41.53 ng/dL ✅1.13 ng/dL ✅0.93 - 1.7⬇️ Dropped (still normal)
TSH1.39 µIU/mL ✅6.110 µIU/mL ⚠️0.54 - 5.3⬆️ RAISED - Above Normal

🚨 Key Finding: Subclinical Hypothyroidism

The pattern here is:
  • TSH: RAISED (6.11 µIU/mL - above the upper limit of 5.3)
  • FT4: Normal (1.13 - within range)
  • FT3: Normal (2.74 - within range)
This is the classic biochemical pattern of Subclinical Hypothyroidism - exactly as confirmed by the lab's own interpretation table printed on the report.
The pituitary is sensing that thyroid hormone levels are slightly insufficient, so it is working harder (producing more TSH) to stimulate the thyroid gland - even though hormone levels have not yet fallen below the normal range.

📉 Trend Analysis

  • FT4 dropped from 1.53 → 1.13 (a 26% drop - significant, though still within range)
  • FT3 dropped from 3.78 → 2.74 (a 28% drop - significant, though still within range)
  • TSH surged from 1.39 → 6.11 (a 340% increase - now outside normal)
This is not a random fluctuation. The coordinated fall in both FT3 and FT4 alongside a sharp TSH rise tells a consistent story of early thyroid under-performance.

🤔 What Are the Likely Reasons for This Change?

Given his age (21 years, male), the most probable causes, ranked by likelihood:

1. 🥇 Hashimoto's Thyroiditis (Chronic Autoimmune Thyroiditis) - Most Likely

  • The most common cause of subclinical/overt hypothyroidism in young people worldwide
  • The immune system produces antibodies (Anti-TPO, Anti-Thyroglobulin) that gradually damage thyroid tissue
  • Can be completely silent for years before TSH starts to rise
  • Critically: This was NOT tested - and this is the #1 next step needed

2. 🥈 Iodine Deficiency

  • Iodine is essential for T3/T4 synthesis
  • Inadequate dietary iodine can impair thyroid hormone production
  • Less common in urban India where iodized salt is standard, but possible

3. 🥉 Physiological/Biological TSH Variability

  • The lab's interpretation table notes that isolated high TSH in the range of 4.7-15 mIU/ml can sometimes reflect physiological variability
  • However, this should only be accepted after ruling out autoimmune and structural causes
  • Less likely given the simultaneous drop in FT3 and FT4

4. Other Contributing Factors

  • Recent illness - viral infections, fever, or systemic illness can transiently alter thyroid hormones (non-thyroidal illness syndrome)
  • Significant stress - physical or psychological stress can temporarily suppress the HPT axis
  • Medication - certain drugs (lithium, amiodarone, beta-blockers, steroids) can raise TSH - though he is self-referred and may not be on any medications
  • Biotin supplements - can cause falsely elevated TSH in ECLIA assays (the method used here)
  • Sleep deprivation / significant weight changes in the last 7 months

✅ What Should He Do Next?

Immediate (Within 1-2 Weeks)

  1. 🔴 See an Endocrinologist or a physician - This result needs clinical correlation with symptoms. Do not self-medicate.
  2. 🧪 Get additional blood tests:
    TestWhy
    Anti-TPO AntibodiesScreen for Hashimoto's - the #1 cause
    Anti-Thyroglobulin AntibodiesComplementary autoimmune marker
    Total T3 & T4For a complete picture
    CBC (Complete Blood Count)Anaemia can co-exist with hypothyroidism
    Lipid ProfileHypothyroidism raises cholesterol
  3. 📋 Tell the doctor about any symptoms such as:
    • Unexplained fatigue or sluggishness
    • Feeling cold more than usual
    • Weight gain without diet change
    • Hair thinning or hair loss
    • Dry skin
    • Brain fog or difficulty concentrating
    • Constipation
    • Low mood or depression
    • Slower heart rate

Short-Term (1-3 Months)

  1. Repeat thyroid panel in 6-8 weeks to confirm - a single elevated TSH reading should ideally be confirmed with a repeat test before starting any treatment
  2. Thyroid Ultrasound - may be recommended by the doctor to check for structural changes, nodules, or features of autoimmune thyroiditis (heterogeneous texture)

Regarding Treatment

  • With TSH of 6.11 (mildly above range) and normal FT3/FT4, treatment is not always immediately started
  • Guidelines suggest treatment is considered when:
    • TSH is persistently >10 µIU/mL, OR
    • TSH is 5-10 with positive Anti-TPO antibodies, OR
    • The patient has clear symptoms
  • If Anti-TPO antibodies come back positive, treatment with Levothyroxine (synthetic T4) is typically initiated
  • Do NOT start any thyroid medication without a doctor's prescription

🧬 Summary

Status
DiagnosisSubclinical Hypothyroidism
SeverityMild (TSH 6.11 - just above upper limit)
Most Likely CauseHashimoto's Autoimmune Thyroiditis (needs confirmation)
UrgencyNon-emergency, but needs follow-up within 1-2 weeks
Immediate ActionConsult a doctor + Anti-TPO antibody test
⚠️ This analysis is for educational purposes only. Narain should consult an endocrinologist or physician for clinical evaluation, symptom correlation, and treatment decisions. Do not start thyroid medication based on this report alone.

Create a summary document on Hashimoto's thyroiditis causes and progression

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Running Command

mkdir -p /tmp/workspace/hashimoto-report && python3 << 'PYEOF' from docx import Document from docx.shared import Pt, Inches, RGBColor from docx.enum.text import WD_ALIGN_PARAGRAPH from docx.oxml.ns import qn from docx.oxml import OxmlElement import datetime doc = Document() # ── Page margins ────────────────────────────────────────────────────────────── from docx.shared import Inches section = doc.sections[0] section.top_margin = Inches(1.0) section.bottom_margin = Inches(1.0) section.left_margin = Inches(1.2) section.right_margin = Inches(1.2) # ── Default body font ───────────────────────────────────────────────────────── normal_style = doc.styles["Normal"] normal_style.font.name = "Calibri" normal_style.font.size = Pt(11) # ── Helper: add a coloured heading ─────────────────────────────────────────── def add_heading(doc, text, level=1, color=(0,70,127)): p = doc.add_heading(text, level=level) for run in p.runs: run.font.color.rgb = RGBColor(*color) return p # ── Helper: bullet paragraph ───────────────────────────────────────────────── def add_bullet(doc, text, bold_prefix=None): p = doc.add_paragraph(style="List Bullet") if bold_prefix: r = p.add_run(bold_prefix + ": ") r.bold = True p.add_run(text) return p # ── Helper: shaded info box ─────────────────────────────────────────────────── def add_shaded_paragraph(doc, text, shade_color="DCE6F1"): p = doc.add_paragraph() p.paragraph_format.left_indent = Inches(0.2) p.paragraph_format.right_indent = Inches(0.2) p.paragraph_format.space_before = Pt(4) p.paragraph_format.space_after = Pt(4) pPr = p._p.get_or_add_pPr() shd = OxmlElement("w:shd") shd.set(qn("w:val"), "clear") shd.set(qn("w:color"), "auto") shd.set(qn("w:fill"), shade_color) pPr.append(shd) run = p.add_run(text) run.font.size = Pt(10.5) run.font.italic = True return p # ═══════════════════════════════════════════════════════════════════════════════ # TITLE PAGE BLOCK # ═══════════════════════════════════════════════════════════════════════════════ title_p = doc.add_paragraph() title_p.alignment = WD_ALIGN_PARAGRAPH.CENTER title_run = title_p.add_run("Hashimoto's Thyroiditis") title_run.font.name = "Calibri" title_run.font.size = Pt(26) title_run.font.bold = True title_run.font.color.rgb = RGBColor(0, 70, 127) sub_p = doc.add_paragraph() sub_p.alignment = WD_ALIGN_PARAGRAPH.CENTER sub_run = sub_p.add_run("Causes, Pathogenesis & Clinical Progression") sub_run.font.name = "Calibri" sub_run.font.size = Pt(16) sub_run.font.color.rgb = RGBColor(70, 130, 180) date_p = doc.add_paragraph() date_p.alignment = WD_ALIGN_PARAGRAPH.CENTER date_run = date_p.add_run(f"Summary Document | {datetime.date.today().strftime('%B %d, %Y')}") date_run.font.size = Pt(11) date_run.font.color.rgb = RGBColor(120,120,120) doc.add_paragraph() # spacer # Horizontal rule via bottom border on a paragraph def add_hrule(doc): p = doc.add_paragraph() pPr = p._p.get_or_add_pPr() pBdr = OxmlElement("w:pBdr") bottom = OxmlElement("w:bottom") bottom.set(qn("w:val"), "single") bottom.set(qn("w:sz"), "6") bottom.set(qn("w:space"), "1") bottom.set(qn("w:color"), "4472C4") pBdr.append(bottom) pPr.append(pBdr) return p add_hrule(doc) doc.add_paragraph() # ═══════════════════════════════════════════════════════════════════════════════ # 1. OVERVIEW # ═══════════════════════════════════════════════════════════════════════════════ add_heading(doc, "1. Overview", level=1) doc.add_paragraph( "Hashimoto's thyroiditis (also called chronic lymphocytic thyroiditis or autoimmune thyroiditis) " "is the most common inflammatory disorder of the thyroid gland and the leading cause of " "hypothyroidism worldwide. First described by Japanese physician Hakaru Hashimoto in 1912 as " "'struma lymphomatosa,' it is characterized by progressive autoimmune destruction of thyroid tissue " "driven by autoreactive T and B lymphocytes. The disease predominantly affects women aged 30-50 years " "but can occur at any age, including in young adults and adolescents." ) add_shaded_paragraph(doc, "Key fact: The annual incidence is up to 4 per 1,000 women and 1 per 1,000 men. " "Subclinical hypothyroidism is found in 6-8% of women and 3% of men. " "The annual risk of progressing to overt hypothyroidism is ~4% when TSH elevation is accompanied " "by positive anti-TPO antibodies.", shade_color="DEEBF7" ) # ═══════════════════════════════════════════════════════════════════════════════ # 2. CAUSES & RISK FACTORS # ═══════════════════════════════════════════════════════════════════════════════ add_heading(doc, "2. Causes & Risk Factors", level=1) doc.add_paragraph( "Hashimoto's thyroiditis arises from a complex interplay of genetic predisposition and " "environmental triggers that collectively cause a breakdown in self-tolerance toward thyroid antigens." ) add_heading(doc, "2.1 Genetic Factors", level=2, color=(0, 100, 0)) doc.add_paragraph( "Autoimmune hypothyroidism is highly heritable. Susceptibility is determined by variants in " "multiple immunoregulatory genes:" ) add_bullet(doc, "HLA-DR3, DR4, and DR5 in Caucasians — the best documented genetic associations (Harrison's, 22e)", bold_prefix="HLA-DR polymorphisms") add_bullet(doc, "PTPN22 and CTLA-4 — both have immunoregulatory functions; polymorphisms confer weak but confirmed risk", bold_prefix="PTPN22 / CTLA-4") add_bullet(doc, "Various cytokine genes, GITR (glucocorticoid-induced TNF-receptor), and STAT3", bold_prefix="Cytokine genes") add_bullet(doc, "A gene on chromosome 21 may explain the high rate of autoimmune thyroiditis in Down syndrome", bold_prefix="Chromosome 21 locus") add_bullet(doc, "X-chromosome-linked genetic factors contribute to female predominance; associated with Turner's syndrome", bold_prefix="X-chromosome factors") doc.add_paragraph( "These genetic associations overlap with those of type 1 diabetes mellitus, Addison's disease, " "pernicious anemia, and vitiligo — explaining the frequent co-occurrence of multiple autoimmune conditions." ) add_heading(doc, "2.2 Environmental Triggers", level=2, color=(0, 100, 0)) add_bullet(doc, "Excess dietary iodine stimulates the thyroid reflexively, increasing autoimmune risk — especially relevant in Japan where the disease is more prevalent", bold_prefix="High iodine intake") add_bullet(doc, "Selenium is essential for antioxidant enzymes in thyroid cells; low selenium increases susceptibility", bold_prefix="Low selenium intake") add_bullet(doc, "Interferon-alpha (used in hepatitis/oncology), lithium, and amiodarone are recognized triggers", bold_prefix="Medications") add_bullet(doc, "Reduced childhood microbial exposure (hygiene hypothesis) has been linked to increased autoimmune thyroid disease", bold_prefix="Reduced microbial exposure") add_bullet(doc, "Smoking cessation has been shown to transiently increase incidence; alcohol intake appears mildly protective", bold_prefix="Smoking & alcohol") add_bullet(doc, "Physical or emotional stress may unmask latent autoimmune processes", bold_prefix="Psychological/physical stress") add_heading(doc, "2.3 Sex & Hormonal Factors", level=2, color=(0, 100, 0)) doc.add_paragraph( "The female-to-male ratio is approximately 10:1 to 20:1. This strong female preponderance is " "attributed to sex steroid effects on the immune response — estrogens generally enhance immune " "reactivity while androgens suppress it. Hormonal shifts during puberty, pregnancy, and menopause " "can all precipitate or worsen thyroid autoimmunity." ) # ═══════════════════════════════════════════════════════════════════════════════ # 3. PATHOGENESIS (MECHANISM) # ═══════════════════════════════════════════════════════════════════════════════ add_heading(doc, "3. Pathogenesis (Mechanism of Disease)", level=1) doc.add_paragraph( "The central event in Hashimoto's thyroiditis is the breakdown of self-tolerance to thyroid " "antigens, leading to chronic inflammation and progressive follicular destruction." ) add_heading(doc, "3.1 Immune Cell Cascade", level=2, color=(0, 100, 0)) steps = [ ("Step 1 - Antigen Presentation", "CD4+ helper T cells are abnormally activated against thyroid antigens " "(thyroglobulin, thyroid peroxidase/TPO, and TSH receptor). This is the initiating event."), ("Step 2 - Cytotoxic T Cell Recruitment", "Activated CD4+ T cells recruit CD8+ cytotoxic T cells (the primary effectors of thyroid " "cell destruction) into the thyroid gland."), ("Step 3 - Cytokine-Mediated Injury", "Locally produced cytokines — TNF-alpha, IL-1, and IFN-gamma — amplify the inflammatory " "response and directly injure thyroid follicular cells."), ("Step 4 - Autoantibody Production", "Activated B cells produce autoantibodies:\n" " • Anti-TPO (thyroid peroxidase) antibodies: present in ~95% of cases\n" " • Anti-thyroglobulin (Anti-Tg) antibodies: present in ~60% of cases\n" " • Anti-TSH receptor antibodies: present in ~60% of cases\n" " • Anti-sodium/iodine symporter: present in ~25% of cases\n" "These antibodies cause complement fixation and NK cell-mediated killing."), ("Step 5 - Apoptosis", "Programmed cell death (apoptosis) of thyrocytes has also been implicated as a key " "destruction mechanism, independent of the antibody-mediated pathway."), ("Step 6 - Fibrosis & Follicular Destruction", "Chronic inflammation leads to fibrosis and progressive loss of functional thyroid follicles, " "ultimately culminating in hypothyroidism."), ] for title, body in steps: p = doc.add_paragraph(style="List Number") r = p.add_run(title + ": ") r.bold = True p.add_run(body) add_heading(doc, "3.2 Role of Autoantibodies", level=2, color=(0, 100, 0)) doc.add_paragraph( "Although anti-TPO and anti-thyroglobulin antibodies are diagnostically useful, the current " "evidence suggests they are markers of the disease rather than the primary cause. They can be " "detected in individuals without thyroid dysfunction. However, their titre level is highly " "predictive of progression severity and speed — higher titres correlate with faster progression " "to overt hypothyroidism." ) # ═══════════════════════════════════════════════════════════════════════════════ # 4. HISTOLOGY (MICROSCOPIC APPEARANCE) # ═══════════════════════════════════════════════════════════════════════════════ add_heading(doc, "4. Histological Appearance", level=1) doc.add_paragraph( "The microscopic picture of Hashimoto's thyroiditis is characteristic and confirms the diagnosis " "when biopsy is performed:" ) add_bullet(doc, "Diffuse infiltration of the gland by small lymphocytes and plasma cells", bold_prefix="Lymphocytic infiltration") add_bullet(doc, "Well-developed germinal center formation within the thyroid parenchyma", bold_prefix="Germinal centers") add_bullet(doc, "Thyroid follicles are smaller than normal with markedly reduced colloid content", bold_prefix="Atrophic follicles") add_bullet(doc, "Follicles lined by Hürthle cells (Askanazy cells) — enlarged cells with abundant eosinophilic, granular cytoplasm; a hallmark finding", bold_prefix="Hürthle/Askanazy cells") add_bullet(doc, "Increased interstitial connective tissue (fibrosis)", bold_prefix="Interstitial fibrosis") doc.add_paragraph( "Gross appearance: The thyroid is usually mildly-to-moderately enlarged, firm, with a pale " "gray-tan, granular, nodular cut surface." ) add_shaded_paragraph(doc, "End-stage (Atrophic Thyroiditis): In advanced disease, fibrosis is much more extensive, " "lymphocyte infiltration is less prominent, and follicles are almost completely absent. " "This represents the burnt-out phase of Hashimoto's thyroiditis rather than a separate entity.", shade_color="FFF2CC" ) # ═══════════════════════════════════════════════════════════════════════════════ # 5. CLINICAL PROGRESSION # ═══════════════════════════════════════════════════════════════════════════════ add_heading(doc, "5. Clinical Progression", level=1) doc.add_paragraph( "Hashimoto's thyroiditis follows a characteristic progression through distinct clinical phases. " "Because the autoimmune process is slow and gradual, patients may remain asymptomatic for years." ) # Progression table table = doc.add_table(rows=1, cols=4) table.style = "Table Grid" hdr_cells = table.rows[0].cells headers = ["Phase", "TSH", "FT3 / FT4", "Clinical State"] for i, h in enumerate(headers): hdr_cells[i].text = h for run in hdr_cells[i].paragraphs[0].runs: run.bold = True # shade header tc = hdr_cells[i]._tc tcPr = tc.get_or_add_tcPr() shd = OxmlElement("w:shd") shd.set(qn("w:val"), "clear") shd.set(qn("w:color"), "auto") shd.set(qn("w:fill"), "2E74B5") tcPr.append(shd) for run in hdr_cells[i].paragraphs[0].runs: run.font.color.rgb = RGBColor(255, 255, 255) rows_data = [ ("Phase 1\nEuthyroid", "Normal (0.54-5.3)", "Normal", "Asymptomatic. Antibodies may be present. No clinical disease."), ("Phase 2\nSubclinical Hypothyroid", "Mildly Elevated (5-10)", "Normal", "Pituitary compensates. Possibly mild fatigue. Often detected only by blood test."), ("Phase 3\nOvert Hypothyroidism", "High (>10)", "Low", "Frank symptoms: fatigue, weight gain, cold intolerance, dry skin/hair, bradycardia, constipation, depression."), ("Phase 4\nAtrophic Thyroiditis", "Very High", "Very Low", "End-stage. Minimal thyroid tissue. Full replacement therapy required."), ("Variant\nHashitoxicosis", "Low", "High", "Transient hyperthyroid phase (4-8% of cases) due to follicular disruption releasing stored hormone."), ] for row_data in rows_data: row_cells = table.add_row().cells for i, val in enumerate(row_data): row_cells[i].text = val doc.add_paragraph() doc.add_paragraph( "Progression rate: 4-18% per year from subclinical to overt hypothyroidism. " "Progression is more likely in patients with:" ) add_bullet(doc, "Higher baseline TSH levels (TSH > 6-10 mIU/L)") add_bullet(doc, "Positive anti-TPO or anti-thyroglobulin antibodies") add_bullet(doc, "Presence of a goiter") add_bullet(doc, "Female sex and advancing age") # ═══════════════════════════════════════════════════════════════════════════════ # 6. CLINICAL FEATURES & SYMPTOMS # ═══════════════════════════════════════════════════════════════════════════════ add_heading(doc, "6. Clinical Features & Symptoms", level=1) doc.add_paragraph( "Symptoms develop insidiously and may be non-specific, particularly in early stages. " "Most patients present with one or more of the following:" ) # Two-column symptom layout using a table sym_table = doc.add_table(rows=1, cols=2) sym_table.style = "Table Grid" sym_h = sym_table.rows[0].cells sym_h[0].text = "Early / Subclinical Stage" sym_h[1].text = "Overt Hypothyroidism Stage" for cell in sym_h: for run in cell.paragraphs[0].runs: run.bold = True tc = cell._tc tcPr = tc.get_or_add_tcPr() shd = OxmlElement("w:shd") shd.set(qn("w:val"), "clear") shd.set(qn("w:color"), "auto") shd.set(qn("w:fill"), "BDD7EE") tcPr.append(shd) sym_rows = [ ("Painless anterior neck mass (goiter)", "Profound fatigue and lethargy"), ("Mild fatigue", "Weight gain without dietary change"), ("Asymptomatic — detected on screening", "Cold intolerance"), ("Mild mood changes", "Dry skin, dry and brittle hair"), ("Possible transient hyperthyroidism (Hashitoxicosis)", "Constipation"), ("", "Bradycardia (slow heart rate)"), ("", "Depression and cognitive slowing ('brain fog')"), ("", "Menstrual irregularities (in women)"), ("", "Hyperlipidaemia (raised cholesterol)"), ("", "Puffy face, periorbital oedema"), ] for r in sym_rows: rc = sym_table.add_row().cells rc[0].text = r[0] rc[1].text = r[1] doc.add_paragraph() # ═══════════════════════════════════════════════════════════════════════════════ # 7. DIAGNOSIS # ═══════════════════════════════════════════════════════════════════════════════ add_heading(doc, "7. Diagnosis", level=1) doc.add_paragraph( "Hashimoto's thyroiditis is primarily a clinical and biochemical diagnosis. " "Key investigations include:" ) add_bullet(doc, "Elevated serum TSH (most sensitive early marker)", bold_prefix="TSH") add_bullet(doc, "Free T4 (to distinguish subclinical from overt hypothyroidism)", bold_prefix="Free T4") add_bullet(doc, "Present in >95% of cases; confirms autoimmune aetiology", bold_prefix="Anti-TPO antibodies") add_bullet(doc, "Present in ~60% of cases; useful when anti-TPO is borderline", bold_prefix="Anti-thyroglobulin antibodies") add_bullet(doc, "Shows heterogeneous, hypoechoic gland consistent with lymphocytic infiltration; not mandatory for diagnosis", bold_prefix="Thyroid ultrasound") add_bullet(doc, "FNAB (fine needle aspiration biopsy): Reserved for suspicious nodules or rapidly enlarging goiter", bold_prefix="Biopsy") add_shaded_paragraph(doc, "Diagnosis is confirmed by: elevated TSH + positive anti-TPO antibodies. " "If TSH is elevated and free T4 is normal → Subclinical Hypothyroidism. " "If TSH is elevated and free T4 is LOW → Overt Hypothyroidism.", shade_color="E2EFDA" ) # ═══════════════════════════════════════════════════════════════════════════════ # 8. ASSOCIATED CONDITIONS # ═══════════════════════════════════════════════════════════════════════════════ add_heading(doc, "8. Associated Conditions", level=1) doc.add_paragraph( "Hashimoto's thyroiditis commonly co-exists with other autoimmune and systemic conditions:" ) add_bullet(doc, "Type 1 Diabetes Mellitus", bold_prefix="Autoimmune") add_bullet(doc, "Addison's disease (autoimmune adrenal insufficiency)", bold_prefix="Autoimmune") add_bullet(doc, "Pernicious anaemia (autoimmune gastritis)", bold_prefix="Autoimmune") add_bullet(doc, "Vitiligo, alopecia areata", bold_prefix="Autoimmune") add_bullet(doc, "Inflammatory bowel disease (IBD), primary biliary cirrhosis, coeliac disease", bold_prefix="GI / Liver") add_bullet(doc, "Sjögren's syndrome, rheumatoid arthritis, systemic lupus erythematosus", bold_prefix="Connective tissue") add_bullet(doc, "Down syndrome, Turner syndrome", bold_prefix="Chromosomal disorders") add_bullet(doc, "Thyroid lymphoma: Rare but 80x higher than background population", bold_prefix="Malignancy risk") # ═══════════════════════════════════════════════════════════════════════════════ # 9. MANAGEMENT OVERVIEW # ═══════════════════════════════════════════════════════════════════════════════ add_heading(doc, "9. Management Overview", level=1) doc.add_paragraph( "There is no treatment that reverses the underlying autoimmune process. Management is directed at " "correcting thyroid hormone deficiency and monitoring progression." ) add_heading(doc, "9.1 Subclinical Hypothyroidism", level=2, color=(0, 100, 0)) doc.add_paragraph("Treatment decision depends on TSH level, symptoms, and antibody status:") add_bullet(doc, "TSH > 10 µIU/mL → treat with levothyroxine (experts agree)", bold_prefix="TSH > 10") add_bullet(doc, "TSH 5-10 µIU/mL → treat if symptomatic, elevated LDL, or positive anti-TPO antibodies", bold_prefix="TSH 5-10") add_bullet(doc, "All others → monitor with repeat TFTs every 6-12 months", bold_prefix="TSH < 5") add_heading(doc, "9.2 Overt Hypothyroidism", level=2, color=(0, 100, 0)) add_bullet(doc, "All patients treated with Levothyroxine (synthetic T4)", bold_prefix="Treatment") add_bullet(doc, "Full replacement dose: 1.6 mcg/kg/day; start lower in elderly or cardiac patients (25-50 mcg/day)", bold_prefix="Dose") add_bullet(doc, "Take on an empty stomach, 30-60 min before breakfast or at bedtime; absorption reduced 40% with food", bold_prefix="Administration") add_bullet(doc, "Calcium, iron, antacids, PPIs, and anticonvulsants all reduce levothyroxine absorption", bold_prefix="Drug interactions") add_bullet(doc, "Recheck TSH 6 weeks after every dose change; once stable, check TSH annually", bold_prefix="Monitoring") add_heading(doc, "9.3 Selenium Supplementation", level=2, color=(0, 100, 0)) doc.add_paragraph( "Selenium supplementation (200 mcg/day) has been shown in some studies to reduce anti-TPO antibody " "titres and may slow disease progression, particularly in early disease. Evidence is still evolving." ) # ═══════════════════════════════════════════════════════════════════════════════ # 10. SUMMARY TABLE # ═══════════════════════════════════════════════════════════════════════════════ add_heading(doc, "10. Quick Reference Summary", level=1) summary_table = doc.add_table(rows=1, cols=2) summary_table.style = "Table Grid" s_hdr = summary_table.rows[0].cells s_hdr[0].text = "Feature" s_hdr[1].text = "Detail" for cell in s_hdr: for run in cell.paragraphs[0].runs: run.bold = True tc = cell._tc tcPr = tc.get_or_add_tcPr() shd = OxmlElement("w:shd") shd.set(qn("w:val"), "clear") shd.set(qn("w:color"), "auto") shd.set(qn("w:fill"), "2E74B5") tcPr.append(shd) for run in cell.paragraphs[0].runs: run.font.color.rgb = RGBColor(255, 255, 255) summary_rows = [ ("Full name", "Hashimoto's thyroiditis / Chronic lymphocytic thyroiditis"), ("First described", "Hakaru Hashimoto, 1912"), ("Type", "Organ-specific autoimmune disease"), ("Primary target", "Thyroid gland (follicular cells)"), ("Main antibodies", "Anti-TPO (95%), Anti-Tg (60%)"), ("Key cells", "CD4+ T helper, CD8+ cytotoxic T cells, B cells"), ("Cytokines involved", "TNF-alpha, IL-1, IFN-gamma"), ("Genetics", "HLA-DR3/4/5, PTPN22, CTLA-4 polymorphisms"), ("Epidemiology", "4/1000 women/yr; 1/1000 men/yr; F:M = 10-20:1"), ("Peak age", "30-50 years (but any age)"), ("Progression rate", "4-18% per year to overt hypothyroidism"), ("Hallmark histology", "Lymphocytic infiltrate + Hürthle cells + fibrosis"), ("Diagnosis", "Elevated TSH + positive Anti-TPO antibodies"), ("Treatment", "Levothyroxine (when indicated)"), ("Rare complication", "Thyroid lymphoma (80x increased risk)"), ] for row_data in summary_rows: rc = summary_table.add_row().cells rc[0].text = row_data[0] rc[1].text = row_data[1] # bold the feature column for run in rc[0].paragraphs[0].runs: run.bold = True doc.add_paragraph() # ── References ──────────────────────────────────────────────────────────────── add_hrule(doc) ref_p = doc.add_paragraph() ref_run = ref_p.add_run("References") ref_run.bold = True ref_run.font.size = Pt(10) ref_run.font.color.rgb = RGBColor(80,80,80) refs = [ "Harrison's Principles of Internal Medicine, 22nd Edition (2025) — Chapter 99: Autoimmune Hypothyroidism", "Schwartz's Principles of Surgery, 11th Edition — Lymphocytic (Hashimoto's) Thyroiditis", "Goldman-Cecil Medicine, International Edition (2-vol set) — Chapter 207: Hypothyroidism Pathobiology", "Berek & Novak's Gynecology — Hashimoto Thyroiditis", "Symptom to Diagnosis: An Evidence-Based Guide, 4th Edition — Hypothyroidism", "Dayan CM et al. Interpretation of thyroid function tests. The Lancet, Vol 357, Feb 2001.", "Laboratory Evaluation of Thyroid Function, Indian Thyroid Guidelines, JAPI, January 2011, Vol 59.", ] for ref in refs: p = doc.add_paragraph(style="List Bullet") r = p.add_run(ref) r.font.size = Pt(9.5) r.font.color.rgb = RGBColor(80,80,80) # ── Disclaimer ──────────────────────────────────────────────────────────────── doc.add_paragraph() disc_p = doc.add_paragraph() disc_p.alignment = WD_ALIGN_PARAGRAPH.CENTER disc_run = disc_p.add_run( "This document is intended for educational purposes only. " "Clinical decisions should always be made in consultation with a qualified healthcare professional." ) disc_run.font.size = Pt(9) disc_run.font.italic = True disc_run.font.color.rgb = RGBColor(150, 150, 150) # ── Save ─────────────────────────────────────────────────────────────────────── out_path = "/tmp/workspace/hashimoto-report/Hashimotos_Thyroiditis_Summary.docx" doc.save(out_path) print(f"Saved: {out_path}") PYEOF

Your summary document is ready for download:

Hashimotos Thyroiditis Summary

Word Document · DOCX

Here is what the document covers across 10 sections, sourced from Harrison's (22e), Schwartz's Surgery, Goldman-Cecil Medicine, and Berek & Novak's Gynecology:
Section 1 - Overview What Hashimoto's is, who it affects, and key prevalence numbers.
Section 2 - Causes & Risk Factors
  • Genetic factors (HLA-DR3/4/5, PTPN22, CTLA-4 polymorphisms, chromosome 21 link to Down syndrome)
  • Environmental triggers (high iodine, low selenium, medications like lithium/amiodarone/interferon, hygiene hypothesis)
  • Sex & hormonal factors (10-20:1 female predominance, estrogen effect on immunity)
Section 3 - Pathogenesis A 6-step immune cascade from CD4+ T cell activation → cytotoxic T cell recruitment → cytokine injury → autoantibody production → apoptosis → fibrosis and follicular destruction.
Section 4 - Histology Lymphocytic infiltrate, germinal centers, Hürthle/Askanazy cells, atrophic follicles, and end-stage atrophic thyroiditis.
Section 5 - Clinical Progression Table Four clearly defined phases (Euthyroid → Subclinical → Overt Hypothyroidism → Atrophic) plus the Hashitoxicosis variant, with TSH/FT4 values for each.
Section 6 - Symptoms Table Side-by-side early vs overt stage symptoms.
Section 7 - Diagnosis TSH + Anti-TPO is the diagnostic cornerstone, with ultrasound and biopsy criteria.
Sections 8-10 Associated conditions, management guidelines (levothyroxine dosing, monitoring), and a quick-reference summary table.
This is a shared conversation. Sign in to Orris to start your own chat.